Bespoke Patient Solutions
The first device, Axis-ALIF was cleared by the FDA in May 2020 with US surgeries starting this fall.
The Axis-Oblique and The Axis-Lateral implant systems will arrive in 2021 and 2022.
The Axis-ALIF offers surgeons intra-operative flexibility to place an implant that more accurately matches a patient’s anatomy whilst also achieving superior corrections than existing interbody devices.
To Correct, To Maintain, To Fuse…
Axis proprietary grafting technology enables easy, in-situ filling and containment of graft, preventing leakage and migration post-operatively.
Axis Technology provides greater intra-operative correction capabilities than expandable cages without the risks associated with small moving parts that can wear or fatigue.
Uncoupled posterior height from lordotic angle
Lordosis to 40 degrees
Unique Coronal Correction Capabilities
To find out more, please contact us via firstname.lastname@example.org
Complete the Surgeon / Sales Distribution enquiry form which follows: